Patient-Centric Formulations Emerge: How Pharma Firms Are Designing Cardiovascular Drugs for Better Adherence
Adherence to cardiovascular drug regimens remains a major challenge, with studies showing 30–50% of patients stop taking prescribed medications within a year. This gap drives poor outcomes and wasted healthcare resources, prompting pharma firms to rethink drug design. Patient-centric formulations—focused on ease of use, reduced side effects, and flexibility—are emerging as a...
0 Commentarios 0 Acciones 367 Views 0 Vista previa
MTSocial https://mtsocial.ir